Recent data on molecular genetics in endocrine tumors;Donnees recentes sur la genetique moleculaire des tumeurs neuro-endocrines

Annales d'Endocrinologie

Volumn 58, Issue 2, 1997, Pages 113-123

  Calender, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

genetic; initiation; neuro endocrine tumors; progression

Indexed keywords

CARCINOGENESIS; CARCINOID; HUMAN; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR; PATHOGENESIS; REVIEW; VON HIPPEL LINDAU DISEASE; ANIMAL; EPIDEMIOLOGY; GENETICS; MULTIPLE ENDOCRINE NEOPLASIA; TUMOR SUPPRESSOR GENE;

ONCOPROTEIN;

ANIMALS; CAUSALITY; GENES, TUMOR SUPPRESSOR; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PROTO-ONCOGENE PROTEINS;

EID: 0030924251     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. ADACHI J, SHISEKI M, OKAZAKI T, ISHIMARU G, NOGUCHI M, HIROHASHI S, YOKOTA J. Microsatellite instability in primary and metastatic lung carcinomas. Genes Chrom Cancer 1995; 14 : 301-6.
2. ARANY I, RADY P, EVERS BM, TYRING SK, TOWSEND CMJR. Analysis of multiple molecular changes in human endocrine tumors. Surg Oncol 1994 ; 3 : 153-9.
3. ARNOLD A. Genetic basis of endocrine diseases : molecular genetics of parathyroid gland neoplasia. J Clin Endocrinol Metab 1993 ; 77 : 1108-12.
4. ASAI N, IWASHITA T, MATSUYAMA M, TAKAHASHI M. Mechanism of activation of the ret proto-oncogene by Multiple Endocrine Neoplasia type 2A mutations. Mol Cell Biol 1995 ; 15 : 1613-19.
5. BARTZ C, ZISKE C, WIEDENMANN B, MOELLING K. p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells. Gut 1996 ; 38 : 403-9.
6. BEIJERSBERGEN RL, CARLÉE L, KERKHOVEN RM, BERNARDS R. Regulation of the retinoblastoma p107 related protein by G1-cyclin complexes. Genes Dev 1995 ; 9 : 1340-53.
7. BERNARDS A. Neurofibromatosis type 1 and RAS-mediated signalling : filling in the GAPs. Biochim Biophys Acta 1995 ; 1242 : 43-59.
8. BOLD RJ, ISHIZUKA J, RAJAMARAN S, PEREZ-POLO JR, TOWNSEND CM Jr, THOMPSON JC. Nerve growth factor as a mitogen for a pancreatic carcinoid cell line. J Neurochem 1995 ; 64 : 2622-8.
9. BOOTHROYD CV, GRIMMOND SM, CAMERON DP, HAYWARD NK. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas. Biochem Biophys Res Commun 1995 ; 211 : 1063-1070.
10. BORDI C, FALCHETTI A, AZZONI C, D'ADDA T, MORELLI A, PERACHIA A, BRANDI ML. Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN 1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN 1 syndrome. Virschows Arch 1995 ; 426 : 203-8.
11. BRANDI ML, MARX SJ, AURBACH GD, FITZPATRICK LA Familial Multiple Endocrine neoplasia type 1 : a new look at physiopathology. Endocrine Rev 1992 ; 13 : 391-405.
12. BYSTROM C, LARSSON C, BLOMBERG C, SANDELIN K, FALKMER U, SKOGSEID B, OBERG K, WERNER S, NORDENSKJOLD M. Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990 ; 87 : 1968-72.
13. CHAUDHRY A, OBERG K. Expression of growth factor peptides and adhesion molecules in endocrine pancreatic tumors. In : Endocrine Tumors of the Pancreas, Mignon M, Jensen RT (eds). Front Gastrointest Res, Basel, Karger, 1995 ; 23 : 132-46.
14. COURSEAUX A, GROSGEORGE J, GAUDRAY P [Nice-France] - PANNETT AJ, FORBES SA, WILLIAMSON C, BASSETT D, THAKKER RV [London-UK] - TEH BT, SHEPERD J, SKOGSEID B, FARNEBO P, LARSSON C [Stockholm-Sweden] - GIRAUD S, ZHANG CX, SALANDRE J, CALENDER A [Lyon-France] for the European Consortium on MEN 1. Definition of the minimal MEN 1 candidate area based on a 5 Mb integrated map of proximal 11q13. Genomics 1996 ; 37 : in press.
15. DOTZENRATH C, TEH B, FARNEBO F, CUPISTI K, SVENSSON A, TOELL A, GORETZKI P, LARSSON C. Allelic loss of the Retinoblastoma tumor suppressor gene : a marker for aggresive parathyroid tumors ? J Clin Endoc Metab 1996 ; 81 : 3194-6.
16. DUAN DR, PAUSE A, BURGESS WH, ASO T, CHEN DY, GARETT KP, CONAWAY RC, CONAWAY JW, LINEHAN WM, KLAUSNER RD. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995 ; 269 : 1402-6.
17. EVERS BM, RADY PL, TYRING SK, SANCHEZ RL, RAJAMARAN S, TOWSEND CM Jr, THOMPSON JC. Amplification of the HER/neu protooncogene in human endocrine tumors. Surgery 1992 ; 112 : 211-7.
18. FRIEDMAN E, LARSSON C, AMOROSI A, BRANDI ML, BALE AE, METZ DC, JENSEN RT, Skarulis MC, EASTMAN RC, NIEMAN L, NORTON JA, MARX SJ. Multiple Endocrine neoplasia type 1 : Pathology, pathophysiology, molecular genetics, and differential diagnosis. In The Parathyroids , Bilezikian JP, Levine MA, Marcus R. (eds), Raven Press Ltd, New-York, 1994 ; chapt. 38 : 647-80.
19. GAUDINO G, AVANTAGGIATO V, FOLLENZI A, ACAMPORA D, SIMEONE A, COMOGLIO RM. The protooncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 1995 ; 11 : 2627-37.
20. GOMEZ MR. Tuberous sclerosis, second edition, 1988 (New York ; Raven Press).
21. GOTZ W, SCHUCHT C, ROTH J, THEURING F, HERKEN R. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice. Am J Pathol 1993 ; 142 : 1493-503.
22. GRIFFITHS DFR, WILLIAMS GT, WILLIAMS ED. Duodenal carcinoid tumours, phaechromocytoma and neurofibromatosis ; islet cell tumor, phaechromocytoma and the Von Hippel-Lindau complex : two distinctive neuroendocrine syndromes. Q J Med 1987 ; 245 : 769-82.
23. GRIMMOND S, WEBER G, LARSSON C, WALTERS M, TEH B, SHEPERD J, NORDENSKJOLD M, HAYWARD N. Exclusion of the 13-Kda rapamycin binding protein gene [FKBP2] as a candidate for multiple endocrine neoplasia type 1. Hum Genet 1995 ; 95 : 455-58.
24. GRIMMOND S, LAGERCRANTZ J, DRINKWATER C, SILINS G, TOWNSON S, POLLOCK P, GOTLEY D, CARSON E, RAKAR S, NORDENSKJOLD M, WARD L, HAYWARD N, WEBER G. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 1996 ; 6 : 124-31.
25. HARVEY M, VOGEL H, LEE EY, BRADLEY A, DONEHOWER LA. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995 ; 55 : 1146-51.
26. HIYAMA K, HIYAMA E, ISHIOKA S, YAMAKIDO M, GAZDAR AF, PIATYSZEK MA, SHAY JW. Telomerase activity in small-cell and non-small-cell lung cancers J Natl Cancer Inst 1995 ; 87 895-902.
27. 4A) asymmetrical hydrolase : sequence similarity histidine triad (HIT) family. Biochem J 1995 ; 312 . 925-32.
28. ILIOPOULOS O, KIBEL A, GRAY S, KAELIN WG. Tumour suppression by the human von Hippel-Lindau gene product. Nature Med 1996 ; 1 : 822-26.
29. JAKOBOVITZ O, NASS D, DEMARCO L, BARBOSA AJA, SIMONI FB, RECHAVI G, FRIEDMAN E. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endoc Metab 1996 ; 81 : 3164-67.
30. JING S, WEN D, YU Y, HOLST PL, LUO Y, FANG M, TAMIR R, ANTONIO L, HU Z, CUPPLES R, LOUIS JC, HU S. ALTROCK BW, FOX GM. GDNF-induced activation of the RET Protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell 1996 ; 85 : 1113-24.
31. KAS K, WEBER G, MICHIELS L, MERREGAERT J, SANDELIN K, SKOGSEID B, THOMPSON N, NORDENSKJÖLD M, LARSSON C, FRIEDMAN E. Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN 1) gene. Hum Mol Genet 1993 ; 2 : 349-53.
32. KIBEL A, ILIOPOULOS O, DECAPRIO JA, KAELIN WG Jr. Binding of the von Hippel-Lindau suppressor protein to Elongin B and C. Science 1995 ; 269 : 1444-46.
33. KIM H, KERR A, MOREHOUSE H. The association between tuberous sclerosis and insulinoma. Am J Neuroradiol 1995 ; 16 : 1543-4.
34. KOH T, YOKOTA J, OOKAWA K, KINA T, KOSHIMURA K, MIWA S, ARIYASU T, YAMADA H, OSAKA M, HAGA H. Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung carcinoma cells. Int J Cancer 1995 ; 60 : 843-847.
35. KOMMINOTH P, ROTH J, MULETTA-FEURER S, SAREMOSLANI P, SERLENTAG WKF, HEITZ PU. RET proto-oncogene point mutations in sporadic neuroendocrine tumors. J Clin Endoc Metab 1996 ; 81 : 2041-46.
36. KNUDSON AG. Mutation and cancer : stastitical study of retinoblastoma. Proc Natl Acad Sci USA 1971 ; 68 : 820-3.
37. LAGERCRANTZ J, CARSON E, PHELAN C, GRIMMOND S, ROSEN A, DARÉ E, NORDENSKJÖLD M, HAYWARD NK, LARSSON C, WEBER G. Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C b3 gene (PLCb3). Genomics 1995 , 26 : 457-72.
38. LARSSON C, SKOGSEID B, OBERG K, NAKAMURA Y, NORDENSKJOLD M. Multiple Endocrine Neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma Nature 1988 ; 332 : 85-7.
39. LIPS CJM, VASEN HF, LAMERS CB. Multiple Endocrine Neoplasia (MEN) syndromes. Crit Rev Oncol Hematol 1984 ; 2 : 117-84.
40. LIU B, EARL HM, BABAN D, SHOBAIBI M, FABRA A, KERR DJ, SEYMOUR LW. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochim Biophys Res Commun 1995 , 217 : 721-7.
41. LOHMANN DR, FESSELER B, PUTZ B, REICH U, BOHM J, PRAUER H, WUNSCH PH, HOFLER H. Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 1995 ; 53 : 5797-5801.
42. LONG PP, HRUBAN RH, LO R. Chromosome analysis of nine endocrine neoplasms of the pancreas. Cancer Genet Cytogenet 1994 ; 77 : 55-9.
43. MAKI M, KANEKO Y, OHTA Y, NAKAMURA T, MACHINAMI R, KUROKAWA K. Somatostatinoma of the pancreas associated with von Hippel-Lindau disease. Intern Med 1995 ; 34 : 661-5.
44. MARX SJ, SAKAGUCHI K, GREEN J III, AURBACH GD, BRANDI ML. Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1. J Clin Endotrinol Metab 1988 ; 67 . 149-53.
45. MOUNT SL, WEAVER DL, TAATJES DJ, MCKINNON WC, HEBERT JC. Von Hippel-Lindau disease presenting as pancreatic neuroendocrine tumour. Virchows Arch 1995 ; 426 : 523-8
46. MULLIGAN LM, ENG C, HEALEY CS, CLAYTON D, KWOK JBJ, GARDNER E, PONDER MA, FRILLING A, JACKSON CE, LEHNERT H, NEUMANNS HPH, THIBODEAU SN, PONDER BAJ. Specific mutations of the ret proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet 1994 ; 6 : 70-74.
47. MULLIGAN LM, MARSH DJ, ROBINSON BG, SCHUFFENECKER I, ZEDENIUS J, LIPS CJM, GAGEL RF, TAKAI SI, NOLL WW, FINK M, RAUE F, LACROIX A, THIBODEAU SN, FRILLING A, PONDER BAJ, ENG C. for the International RET Mutation Consortium. Genotype-phenotype correlation in multiple endocrine neoplasia type 2 (MEN 2) : report of the International RET mutation consortium. J Int Med 1995 ; 238 : 343-6.
48. MURPHY D, BISHOP A, RINDI G, MURPHY MN, STAMP GW, HANSON J, POLAK JM, HOGAN B. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1. Am J Pathol 1987 , 129 : 552-566.
49. NAKAMURA Y, LARSSON C, JULIER C, BYSTROM C, SKOGSEID B, WELLS S, OBERG K, CARLSON M, TAGGART T, O'CONNELL P, LEPPERT M, LALOUEL JM, NORDENSKJOLD M, WHITE R. Localization of the genetic defect in Multiple Endocrine Neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet 1989 ; 44 : 751-5.
50. NILSSON O, WANGBERG B, KOLBY L, SCHULTZ GS, AHLMAN H. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer 1995 ; 60 : 645-51.
51. OHTA M, INOUE H, COTTICCELLI MG, KASTURY K, BAFFA R, PALAZZO J, SIPRASHVILI Z, MORI M, MCCUE P, DRUCK T, CROCE CM, HUEBNER K. The human FIHT gene, spanning the chromosome 3p14-2 fragile site and renal carcinoma-associated translocation breakpoint, is abnormal in digestive tract cancers Cell 1996 ; 84 : 587-97.
52. OKAMOTO A, HUSSAIN SP, HAGIWARA K, SPILLARE EA, RUSIN MR, DEMETRICK DJ, SERRANO M, HANNON GJ, SHISEKI M, ZARIWALA M. Mutations in the p16INK4A/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancers. Cancer Res 1995 ; 55 : 1448-51.
53. OOKAWA K, SHIKESI M, TAKAHASHI R, YOSHIDA Y, TERADA M, YOKOTA J. Reconstitution of the Rb gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene 1993 , 8 : 2175-81.
54. PANG JT, LLOYD SE, WOODING C, FARREN B, POTTINGER B, HARDING B, LEIGH SE, POOK MA, BENHAM FJ, GILLETT GT, TAGGART RT, THAKKER RV. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of μ-calpain as multiple endocrine neoplasia type 1 gene. Hum Genet 1996 ; 97 : 732-41
55. PEARSE AGE. The diffuse neuroendocrine system and the APUD concept related « endocrine » peptides in brain, intestine, pituitary, placenta and anuran cutaneous glands. Med Biol 1977 ; 55 : 115-125.
56. PETTY EM, GREEN JS, MARX SJ, TAGGART T, FARID N. BALE AE. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN IBURIN) to chromosome 11q : evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 1994 ; 54 : 1060-6.
57. POLACK JM, BLOOM SR. The Endocrine Pancreas. In : Oxford Textbook of Pathology. McGee JO, Isaacson PG, Wright NA, eds. 1992 ; vol. 2b : 1997-2009.
58. PRZYGODZKI RM, FINKELSTEIN SD, LANGER JC, SWALSKY PA, FISHBACK N, BARKER A, GUINEE DG, KOSS M, TRAVIS WD. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors : correlation with histological subtype and clinical outcome Am J Pathol 1996 ; 148 : 1531-41.
59. RADFORD DM, ASHLEY SW, WELLS Jr SA, GERHARD DS. Loss of heterozygosity of markers on chromosome 11 in tumours from patients with multiple endocrine neoplasia syndrome type 1 (MEN 1). Cancer Res 1990 ; 50 : 6529-33.
60. RICCARDI VM. Neurofibromatosis. Phenotype, natural history and pathogenesis. In : The John Hopkins University Press, 1992, Baltimore.
61. RICHARDS FM, SCHOFIELD PN, FLEMING S, MAHER ER. Expression of the von Hippel-Lindau tumour suppressor gene during human embryogenesis. Hum Mol Genet 1996 ; 5 : 639-44.
62. RINDI G, GRANT SG, YIANGOU Y, GHATEI MA, BLOOM SR, BAUTCH VL, SOLCIA E, POLAK JM. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Am J Pathol 1990 ; 136 : 1349-63.
63. RINDI G, BISHOP AE, MURPHY D, SOLCIA E, HOGAN B, POLAK JM. A morphological analysis of endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice. Virschows Arch Pathol Anat Histopathol 1988 ; 412 : 255-66.
64. RINDI G, TERENGHI G, WESTERMARK G, WESTERMARK P, MOSCOSO G, POLAK JM. Islet amyloid polypeptide in proliferative pancreatic B cells during developmemnt, hyperplasia and neoplasia in humans and mice. Am J Pathol 1991 ; 138 : 1321-34.
65. SAGARA M, SUGIYAMA F, HORIGUCHI H, KAMMA H, OGATA T, YAGAMI K, MURAKAMI K, FUKAMIZU A. Activation of the nuclear oncogenes N-myc and C-jun in carcinoid tumors of transgenic mice carrying the human adenovirus type 12 E1 region gene. DNA Cell Biol 199 ; 14 : 95-101.
66. SAMPSON JR, JANSSEN LAJ, SANDKUIJL LA and the Tuberous Sclerosis Collaborative Group Linkage investigation of three putative tuberous sclerosis determining loci on chromosomes q, 11q, and 12q. J Med Genet 1992 ; 29 : 861-6.
67. SAWICKI MP, WAN YJT, JOHNSON CL, BERENSOPN J, GATTI R, PASSARO E. Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum Genet 1992 ; 89 : 445-9.
68. SCHWINDINGER WF, FRANCOMANO CA, LEVINE MA. Identification of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl-cyclase in Mc Cune-Albright syndrome. Proc natl Acad Sci USA 1992 ; 89 : 5152-5156.
69. SHAPIRO GI, ROLLINS BJ. p16INK4A as a human tumor suppressor. Biochim Biophys Acta 1996 ; 1242 : 165-9.
70. SHEPERD JJ. The natural history of multiple endocrine neoplasia type 1 : highly uncommon or highly unrecognized ? Arch Surg 1991 ; 126 : 935-52.
71. SKOGSEID B. Multiple Endocrine neoplasia type 1 : clinical biochemical and genetic investigations. Acta Univ Ups 1990 ; 252 : 1-43.
72. SKOGSEID B, RASTAD J, GOBL A, LARSSON C, BACKLIN K, JUHLIN C, AKERSTROM G, OBERG K. Adrenal lesions in multiple endocrine neoplasia type 1. Surgery 1995 ; 118 : 1077-82.
73. SOZZI G, VERONESE ML, NEGRINI M, BAFFA R, COTTICCELLI MG, INOUE H, TORNSELLI S, PILOTTI S, DE GREGORIO L, PASTORINO U, PIEROTTI MA, OHTA M, HUEBNER K, CROCE CM. The FIHT gene at 3p14-2 is abnormal in lung cancer. Cell 1996 ; 85 : 17-25.
74. STRIDSBERG M, ERIKSSON B, LUNDQVIST G, SKOGSEID B, WILANDER E, OBERG K, Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumors. Regul Pept 1995 ; 55 : 119-1.
75. SWINBURN BA, YEONG ML, LANE MR, NICHOLSON GI, Holdaway IM. Neurofibromatosis associated with somatostatinoma : a report of two patients. Clin Endocrinol 1988 ; 28 : 353-59.
76. TERRIS B, FLÉJOU F, DUBOIS S, RUSNIEWSKI P, BELGHITI J, POTET N, BERNADES P, MIGNON M, HÉNIN D. Increased expression of CD44v6 in endocrine pancreatic tumors but not in midgut carcinoid tumors. Gastroenterology 1996 (AGA report) ; 110 : A437.
77. THAKKER RV, BOULOUX P, WOODING C, CHOTAI K, BROAD PM, SPURR NK, BESSER GM, O'RIORDAN JLH. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989 ; 321 : 218-224.
78. TODA T, IIDA A, MIWA T, NAKAMURA Y, IMAI T. Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN 1). Hum Mol Genet 1994 ; 3 : 465-70.
79. TOMASSETTI P, COMETA G, DEL VECCHIO E, BASERGA M, FACCIOLI P, BOSONI D, PAOLUCCI G, BARBARA L. Chromosomal instability in Multiple Endocrine Neoplasia type 1 : cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 1995 ; 79 : 123-126.
80. VAN BASTEN JP, VAN HOEK B, DE BRUINE A, ARENDS JW, STOCKBRUGGER RW. Ampullary carcinoid and neurofibromatosis : case report and review of the literature. Neth J Med 1994 ; 44 : 202-6.
81. VISKOCHIL D, BUCHBERG AM, XU G, CAWTHON RM, STEVENS J, WOLFF RK, CULVER M, CAREY JC, COPELAND NG, JENKINS NA, WHITE R, O'CONNELL P. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus Cell 1990 ; 62 : 187-92.
82. VON HERBAY A, SIEG B, SCHUMANN G, HOFMANN WJ, BETZLER M, OTTO HF. Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic system - DNA flow cytometric and immunohistological investigations. Gut 1991 ; 32 : 949-53.
83. WAGNER SN, MULLER R, BOEHM J, PUTZ B, WUNSCH PH, HOFLER H. Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras. Virchows Arch B Cell Pathol 1993 ; 63 : 325-9
84. WIENECKE R, KONIG A, DECLUE JE. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem 1995 ; 270 : 14609-14.
85. WILLIAMS ED. The classification of carcinoid tumours. Lancet 1963 ; 1 : 238-43.
86. ZUO L, WEGER J, YANG Q, GOLDSTEIN AM, TUCKER MA, WALKER GJ, HAYWARD N, DRACOPOLI NC. Germline mutations in the p16INK4A binding domain of CDK4 in familial melanoma. Nature Genet 1996 ; 12 . 97-9.